Gabapentin in comorbid anxiety and substance use.
Verduin
Marcia L
ML
McKay
Scot
S
Brady
Kathleen T
KT
D000328:Adult; D000588:Amines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000453:epidemiology*; D003509:Cyclohexanecarboxylic Acids / Q000493:pharmacokinetics / Q000627:therapeutic use*; D062787:Drug Overdose; D000077206:Gabapentin; D006801:Humans; D008297:Male; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology*; D005680:gamma-Aminobutyric Acid / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000588:Amines; D014151:Anti-Anxiety Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin